Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency

NCT01513369 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

152

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Iron Deficiency

Interventions

DRUG: ferric carboxymaltose
DRUG: NaCl (0,9%)

Sponsor

GWT-TUD GmbH

Collaborators

[object Object]